Page last updated: 2024-08-16

practolol and Hepatocellular Carcinoma

practolol has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
di Bartolomeo, S; Spinedi, A	1

Other Studies

1 other study(ies) available for practolol and Hepatocellular Carcinoma

Article	Year
Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells. Biochemical and biophysical research communications, 2001, Oct-19, Volume: 288, Issue:1 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Ceramides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Glucosyltransferases; Humans; Liver Neoplasms; Morpholines; Propanolamines; Pyrrolidines; Tumor Cells, Cultured	2001

Article

Year

Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.

Biochemical and biophysical research communications, 2001, Oct-19, Volume: 288, Issue:1

Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Ceramides; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Glucosyltransferases; Humans; Liver Neoplasms; Morpholines; Propanolamines; Pyrrolidines; Tumor Cells, Cultured

2001